NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
AlsTrumpFebruaryMajorDane'sResearchElectionCandidateCampaignPartyStrikesNewsDigestSundayTimelineLaunchesPrivateGlobalCongressionalCrisisPoliticalEricBlueCredit
AlsTrumpFebruaryMajorDane'sResearchElectionCandidateCampaignPartyStrikesNewsDigestSundayTimelineLaunchesPrivateGlobalCongressionalCrisisPoliticalEricBlueCredit
All Articles
STAT+: Element Biosciences launches table-top sequencer capable of $100 genome
STAT News
Published 2 days ago

STAT+: Element Biosciences launches table-top sequencer capable of $100 genome

STAT News · Feb 20, 2026 · Collected from RSS

Summary

And other biotech news brought to you by The Readout newsletter

Full Article

And other biotech news brought to you by The Readout newsletter APStock Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Grail’s Galleri blood test just failed a make-or-break NHS trial, missing its primary endpoint and reviving the uncomfortable question: Does earlier detection actually change outcomes, or just the timeline for diagnoses? And there’s more news out of the FDA: The agency has installed an AI industry vet to steer digital health, and new CDER chief Tracy Beth Høeg tells staff she’s keen to revisit SSRIs in pregnancy and scrutinize RSV monoclonals. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe Biotech Correspondent Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Share this story
Read Original at STAT News

Related Articles

STAT News1 day ago
STAT+: Nature Medicine to investigate study that found cancer treatment is better in morning

Nature Medicine starts an investigation into inconsistencies in a study that found it was better to have immunotherapy in the morning.

STAT News1 day ago
STAT+: DOJ, Ohio attorney general accuse OhioHealth of driving up prices, crowding out competition

Regulators say Ohio hospital system made it difficult for health insurers to offer cheaper plans.

STAT News2 days ago
STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

STAT News2 days ago
STAT+: Pharmalittle: We’re reading about an FDA official’s speech, a Grail cancer blood test, and much more

The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV

STAT News2 days ago
ACIP meeting postponed, for reasons that are unclear

And other health news from today's Morning Rounds newsletter

STAT News2 days ago
Opinion: STAT+: Sometimes, it would be unethical not to use AI in medicine

“We do not let pilots fly without instrument support simply because they technically could. Why should medicine be different?”